Significance of cell proliferation markers (minichromosome maintenance protein 7, topoisomerase IIα and Ki-67) in cavital fluid cytology: Can we differentiate reactive mesothelial cells from malignant cells?

Diagnostic Cytopathology

Volumn 38, Issue 3, 2010, Pages 161-167

  Kimura, Fumikazu ^a   Kawamura, Jumpei ^a   Watanabe, Jun ^b   Kamoshida, Shingo ^c   Kawai, Kenji ^d   Okayasu, Isao ^b   Kuwao, Sadahito ^a  

^a Higashiyamato Hospital   (Japan)

^b KITASATO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^c KOBE UNIVERSITY   (Japan)

^d CENTRAL INSTITUTE FOR EXPERIMENTAL ANIMALS   (Japan)

Author keywords

Cavital fluid cells; Immunocytochemistry; Ki 67; Minichromosome maintenance protein 7; Topoisomerase II

Indexed keywords

DNA TOPOISOMERASE (ATP HYDROLYSING); KI 67 ANTIGEN; MINICHROMOSOME MAINTENANCE PROTEIN 7; TOPOISOMERASE 2 ALPHA; UNCLASSIFIED DRUG;

ADULT; ARTICLE; CANCER CELL; CELL PROLIFERATION; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOLOGY; DIFFERENTIAL DIAGNOSIS; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOCYTOCHEMISTRY; IMMUNOPEROXIDASE STAINING; LUNG ADENOCARCINOMA; LUNG SMALL CELL CANCER; LUNG SQUAMOUS CELL CARCINOMA; MALE; MESOTHELIUM CELL; PLEURA MESOTHELIOMA; PRIORITY JOURNAL; SENSITIVITY AND SPECIFICITY; THORACIC CAVITY;

ADENOCARCINOMA; AGED; ANTIGENS, NEOPLASM; ASCITIC FLUID; CARCINOMA, SQUAMOUS CELL; CELL CYCLE PROTEINS; CELL PROLIFERATION; DNA TOPOISOMERASES, TYPE II, EUKARYOTIC; DNA-BINDING PROTEINS; EPITHELIUM; FEMALE; HUMANS; IMMUNOENZYME TECHNIQUES; KI-67 ANTIGEN; MALE; MESOTHELIOMA; NUCLEAR PROTEINS; PERITONEAL NEOPLASMS; PLEURAL NEOPLASMS; SMALL CELL LUNG CARCINOMA; THORACIC CAVITY; TUMOR MARKERS, BIOLOGICAL;

EID: 76149113586     PISSN: 87551039     EISSN: 10970339     Source Type: Journal    
DOI: 10.1002/dc.21190     Document Type: Article

References (34)

1. Schönherr A, Bayer M, Böcking A. Diagnostic and prognostic value of Ki67 proliferation fraction in serous effusions. Cell oncol 2004;26:57-62.
2. Brown DC, Gatter KC. Monoclonal antibody Ki-67: Its use in histopathology. Histopathology 1990;17:489-503.
3. Scholzen T, Gerdes J. The Ki-67 proten: From the known and the unknown. J Cell Physiol 2000;182:311-322.
4. Abele MC, Valente G, Kerim S, et al. Significance of cell proliferation index in assessing histological prognostic categories in Hodgkin's disease. An immunohistochemical study with Ki67 and MIB-1 monoclonal antibodies. Haematologica 1997;82:281-285.
5. Rudolph P, Kellner U, Chassevent A, et al. Prognostic relevance of a novel proliferation marker, Ki-S11, for soft-tissue sarcoma. a multivariate study. Am J Pathol 1997;150:1997-2007.
6. Spyratos F, Ferrero-Poüs M, Trassard M, et al. Correlation between MIB-1 and other proliferation markers: Clinical implications of the MIB-1 cut-off value. Cancer 2002;94:2151-2159.
7. Tuteja N, Tuteja R. Prokaryotic and eukaryotic DNA helicases. Eur J Biochem 2004;271:1835-1848.
8. Tachibana KE, Gonzalez MA, Coleman N. Cell-cycle-dependent regulation of DNA replication and its relevance to cancer pathology. J Pathol 2005;205:123-129.
9. Pucci B, De Felice M, Rossi M, Onesti S, Pisani FM. Amino acids of the Sulfolobus solfataricus mini-chromosome maintenance-like DNA helicase involved in DNA binding/remodeling. J Biol Chem 2004;279:49222-49228.
10. Tye BK. MCM proteins in DNA replication. Annu Rev Biochem 1999;68:649-686.
11. Davies RJ, Freeman A, Morris LS, et al. Analysis of minichromosome maintenance proteins as a novel method for expression of colorectal cancer in stool. Lancet 2002;359:1917-1919.
12. Freeman A, Morris LS, Mills AD, et al. Minichromosome maintenance protein as biological markers of dysplasia and malignancy. Clin Cancer Res 1999;5:2121-2132.
13. Ishimi Y, Okayasu I, Kato C, et al. Enhanced expression of MCM proteins in cancer cells derived from uterine cervix. Eur J Biochem 2003;270:1089-1101.
14. Li SS, Xue WC, Khoo US, et al. Replicative MCM7 protein as a proliferation marker in endometrial carcinoma: A tissue microarray and clinicopathological analysis. Histopathology 2005;46: 307-313.
15. Nishihara K, Shomori K, Fujioka S, et al. Minichromosome maintenance protein 7 in colorectal cancer: Implication of prognostic significance. Int J Oncol 2008;33:245-51.
16. Fujioka S, Shomori K, Nishihara K, et al. Expression of minichromosome maintenance 7 (MCM 7) in small lung adenocarcinomas (pT1): Prognostic implication. Lung Cancer 2009; in press.
17. You Z, Ishimi Y, Masai H, Hanaoka F. Roles of Mcm7 and Mcm4 subunits in the DNA helicase activity of the mouse Mcm4/6/7 complex. J Biol Chem 2002;277:42471-42479.
18. Bechert T, Diekman S, Arndt-Jovin DJ. Human 170 kDa and 180 kDa topoisomerase II bind preferentially to curved and left handed linear DNA. J Biomol Struct Dyn 1994;12:605-623.
19. Morgarete M, Heck S, Hittelman WN, Earnshaw WC. Differential expression of DNA topoisomerase I and II during the eukaryotic cell cycle. Proc Natl Acad Sci USA 1988;85:1086-1090.
20. Wang JC. Cellular roles of DNA topoisomerases: A molecular perspective. Nat Rev Mol Cell Biol 2002;3:430-440.
21. Ito K, Sasano H, Yabuki N, et al. Immunohistochemical study of Ki-67 and DNA topoisomerase II in human endometrium. Mod Pathol 1997;10:289-294.
22. Yabuki N, Sasano H, Kato K, et al. Immunohistochemical study of DNA topoisomerase II in human gastric disorders. Am J Pathol 1996;149:997-1006.
23. Nishimura Y, Watanabe J, Jobo T, Hattori M, Arai T, Kuramoto H. Cytologic scoring of endometrioid adenocarcinoma of the endometrium. Cancer Cytopathol 2005;105:8-12.
24. Schaarschmidt D, Landenburger EM, Keller C, Knippers R. Human Mcm proteins at a replication origin during to G1 to S phase transition. Nucleic Acids Res 2002;30:4176-4185.
25. Landberg G, Tan EM, Roos G. Flow cytometric multiparameter analysis of proliferating cell nuclear antigen/cyclin and Ki-67 antigen: A new view of the cell cycle. Exp Cell Res 1990;187:111-118.
26. Bruno S, Darzynkiewicz Z. Cell cycle dependent expression and stability of the nuclear protein detected by Ki-67 antibody in HL-60 cells. Cell Prolif 1992;25:31-40.
27. Bruno S, Crissman HA, Bauer KD, Darzynkiewicz Z. Changes in cell nuclei during S phase: Progressive chromatin condensation and altered expression of the proliferation-associated nuclear Ki-67, cyclin (PCNA), p105, and p34. Exp Cell Res 1991; 196:99-106.
28. Wilsman NJ, Farnum CE, Green EM, Lieferman EM, Clayton MK. Cell cycle analysis of proliferative zone chondrocytes in growth plates elongating at different rate. J Orthop Res 1996;14: 562-572.
29. KIP1 on cell cycle and apoptosis in gastric cancer cells. World J Gastroenterol 2005;11:7072-7077.
30. Cip1/Waf1 at both the G1/S and the G2/M cell cycle transitions: pRb is a critical determinant in bloking DNA replication and preventing endoreduplication. Mol Cell Biol 1998;18:629-643.
31. Takahashi M. Color atlas of cancer cytology. 2nd ed. Tokyo: Igaku-Shoin Medical Publishers Inc; 1981. p 18-19.
32. Hayashi Y, Fukayama M, Koike M, Kaseda S, Ikeda T, Yokoyama T. Cell-cycle analysis detecting endogenous nuclear antigens: Comparison with BrdU-vivo labeling and an application to lung tumors. Pathol Int 1993;43:313-319.
33. Kawai T, Suzuki M, Kono S, et al. Proliferating cell nuclear antigen and Ki-67 in lung carcinoma. Cancer 1994;74:2468-2475.
34. Saleh H, Bober P, Tabaczka P. Value of Ki67 immunostain in identification of malignancy in serous effusions. Diagn Cytopathol 1999;20:24-28.